drugset / Trial / NCT00758836

A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)

NCT00758836

Phase 2 Completed 683 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will test the safety and how effective telcagepant is when taken with ibuprofen or acetaminophen in participants with migraine with or without aura. The primary study hypothesis is that at least one drug combination is superior to telecagepant alone in the treatment of acute migraines.

Timeline

Start
2008-12-03
Primary completion
2009-08-24
Completion
2009-08-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg Oral
Subject Ibuprofen Small molecule 400 mg Oral
Subject Telcagepant Small molecule 280 mg Oral

Indications